Paclitaxel-eluting balloon catheter - Eurocor/Biosensors International Group

Drug Profile

Paclitaxel-eluting balloon catheter - Eurocor/Biosensors International Group

Alternative Names: BioPath 014; BioPath 035; BioStream; FREEWAY; FREEWAY 014; Freeway 014 paclitaxel releasing balloon catheter; FREEWAY 035; Freeway 035 paclitaxel releasing balloon catheter; Freeway paclitaxel balloon catheter

Latest Information Update: 14 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Eurocor
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Platelet-derived growth factor inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Peripheral arterial occlusive disorders

Most Recent Events

  • 30 May 2013 Biomarkers information updated
  • 01 May 2011 Phase-III clinical trials in Peripheral arterial occlusive disorders in Colombia, Germany, Italy, Spain and Austria (Intra-arterial) (NCT01960647)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top